Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R01LM013477-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Library of Medicine (NLM) | NIH |
Not provided
Not provided
Not provided
Not provided
This is a randomized pilot study to test the acceptance and use of PerHL among formerly incarcerated individuals
Eligible participants will be enrolled after providing informed consent .Participants will then complete a baseline assessment. After the interview, eligible participants will be randomly assigned to the intervention or control group. The research assistant (RA) will be blinded to the randomization allocation until after the consent process. For the purposes of this study, permuted block randomization with random block sizes of 2, 4 and 6 will be used.
Intervention: Those randomized to the intervention arm will have access to PerHL. The intervention group will watch a demonstration by the RA and will practice using PerHL for 10-15 minutes, i.e. taking a picture of a document and uploading to PerHL, entering specific information, voice recording an appointment reminder. The RA will be responsible for providing technical support and assist with the need for initial support, e.g. phone-call or text-based support. At baseline, participants will be asked to provide a list of every organization they visited that may have health and health-related social information on them and receive consent to request their information to be sent to the participant and the study team on their behalf.
Control: Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart). The RA will give them an informational pamphlet outlining key features of the patient portal and guide them through the steps for signing up for a MyChart account, assist them to sign up, add the standard patient portal MyChart app to their phone, and provide them with the MyChart technical support hotline.
Study Procedures: During the intervention phase, all participants will meet with the RA at baseline, 1- and 3 months. During the study, each participant will be asked to provide at least 5 verified locators who are likely to have knowledge of their whereabouts throughout follow-up. Each participant will be provided with $50 payment to participants for each completion of surveys at baseline, 1, 3 months. In addition, participants will be given $10 each month to travel to a location with free wireless so their information can be uploaded to the cloud and a list of available locations. In total, each participant will receive $180 for participation.
For the 1- and 3-month follow-up period, the RA will ask participants to bring information collected and uploaded in PerHL and additional information that is important to the participant but was not uploaded.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Access to Personal Health Library (PerHL) + MyChart | Experimental | Participants randomized to the PerHL arm will have access to PerHL and the standard of care patient portal (Epic®MyChart). |
|
| Control - MyChart | Active Comparator | Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Personal Health Library (PerHL) + MyChart | Device | Participants randomized to the PerHL arm will have access to PerHL + the standard of care patient portal (Epic®MyChart). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Acceptance - Intention to use | Assess intention to use the app developed for the project. Intention to use will be assessed by a survey conducted in person. This survey item is in development. | 1 month post enrollment |
| Acceptance - Intention to use | Assess intention to use the app developed for the project. Intention to use will be assessed by a survey conducted in person. This survey item is in development. | 3 month post enrollment |
| Use of Personal health information technology | Assess the number of times the personal health information app was accessed each week and the duration of time on the system per week. This will be assessed using tracking functionality built into the app. | 1 month post enrollment |
| Use of Personal health information technology | Assess the number of times the personal health information app was accessed each week and the duration of time on the system per week. This will be assessed using tracking functionality built into the app. | 3 month post enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Perceived ease of use for the app | Assess how easy it was for the participant to use the app. Perceived ease of use will be assessed by self-report survey. This survey item is in development. | 1 month post enrollment |
| Perceived ease of use for the app |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kimberly Vasquez, MPH | Contact | 2123630809 | kimberly.vasquez@yale.edu |
| Name | Affiliation | Role |
|---|---|---|
| Karen Wang, MD, MHS | Yale University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yale School of Medicine | New Haven | Connecticut | 06510 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Epic®MyChart | Device | Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart). |
|
Assess how easy it was for the participant to use the app. Perceived ease of use will be assessed by self-report survey. This survey item is in development. |
| 3 month post enrollment |
| Perceived usefulness of the app | Assess how useful the participant found app to be. Perceived usefulness will be assessed by self-report survey. This survey item is in development. | 1 month post enrollment |
| Perceived usefulness of the app | Assess how useful the participant found app to be. Perceived usefulness will be assessed by self-report survey. This survey item is in development. | 3 month post enrollment |
| Attitude towards use of technology | Assess the participant's attitude towards using technology. Attitude towards technology will be assessed by self-report survey. This survey item is in development. | 1 month post enrollment |
| Attitude towards use of technology | Assess the participant's attitude towards using technology. Attitude towards technology will be assessed by self-report survey. This survey item is in development. | 3 month post enrollment |
| Completeness of data | Assess the proportion of health system data sources received by study team and/or patient (#organizational data received/ #organizational requests made), assess type of data received (# of medication list received/ requested or # of allergies received/requests made) to determine completeness of data. | 1 month post enrollment |
| Completeness of data | Assess the proportion of health system data sources received by study team and/or patient (#organizational data received/ #organizational requests made), assess type of data received (# of medication list received/ requested or # of allergies received/requests made) to determine completeness of data. | 3 month post enrollment |
| General self-efficacy | Assess participant self-efficacy. Self-efficacy will be assessed by self-report survey. This survey item is in development. | 1 month post enrollment |
| General self-efficacy | Assess participant self-efficacy. Self-efficacy will be assessed by self-report survey. This survey item is in development. | 3 month post enrollment |
| Medication adherence | Medication Adherence will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, medication adherence (as measured by ninety-day medication refill). | 1 month post enrollment |
| Medication adherence | Medication Adherence will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, medication adherence (as measured by ninety-day medication refill). | 3 month post enrollment |
| Engagement in primary care | Engagement in primary care will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, engagement in primary care (as measured by appointments made) via MyChart systems. | 1 month post enrollment |
| Engagement in primary care | Engagement in primary care will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, engagement in primary care (as measured by appointments made) via MyChart systems. | 3 month post enrollment |